<DOC>
	<DOCNO>NCT02145208</DOCNO>
	<brief_summary>The study include implantation TIND device 4 follow visit 12 month implantation .</brief_summary>
	<brief_title>Study Assess Efficacy Medi-Tate TIND Device</brief_title>
	<detailed_description>After screen , eligible patient undergo implantation procedure ( operative ) , use TIND device . Implantation perform accord Instructions For Use . Between 5th - 7th day , TIND retrieve rigid cystoscope sheath , direct vision . Before retrieval subject ask subjective discomfort evaluation level urgency past day device insertion , AE device retrieve . The next visit 4 week ( post device retrieval ) , 3 month , 6 month , 12 month post implantation optional extension follow period ( 36 month ) . In visit follow assessed : Uroflow residual urine volume test , AE recording , IPSS , Questions sex perform capability ejaculation fill subject , local language .</detailed_description>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<criteria>Subject sign informed consent prior performance study procedure . Male symptomatic BPH . IPSS symptom severity score 10 . Peak urinary flow 12 ml/sec Prostate volume 75 ml Blood CBC biochemistry two week screen demonstrating : Normal value PT , PTT INR test ( anticoagulant stop accord GCP ) Subject able complete study protocol . Normal Urinalysis urine culture cardiac arrhythmia , cardiac disease include congestive heart failure , uncontrolled diabetes mellitus , significant respiratory disease , know immunosuppression ; neurogenic bladder and/or sphincter abnormality due Parkinson 's disease , multiple sclerosis , cerebral vascular accident , diabetes , etc . ; post void residual ( PVR ) volume 250 ml measure ultrasound acute urinary retention compromise renal function ( i.e. , serum creatinine level 1.8 mg/dl , upper tract disease ) ; confirm suspected bladder cancer ; recent ( within 3 month ) cystolithiasis hematuria ; urethral stricture , bladder neck contracture , Urinary bladder stone potentially confound bladder pathology ; active urinary tract infection . Enrolled another treatment trial disease within past 30 day . previous rectal surgery ( hemorrhoidectomy ) history rectal disease therapy may potentially cause injury site previous rectal surgery , e.g. , transrectal probe use ; previous pelvic irradiation radical pelvic surgery ; previous prostate surgery , balloon dilatation , stent implantation , laser prostatectomy , hyperthermia , invasive treatment prostate Cancer consider cure , except basal cell squamous cell carcinoma skin ( cure define evidence cancer within past 5 year ) . Subject interest future fertility willing undergo fertility treatment whatsoever . Any serious medical condition likely impede successful completion study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>BPH</keyword>
</DOC>